Renowned private equity firm, TPG Growth has recently announced plans to invest $30 million in Chennai-based active pharmaceutical ingredients (API) manufacturer, Solara Active Pharma.
Read more : http://healthcareopportunity.org/tpg-growth-to-pour-30-million-in-indian-drug-maker-solara-active/
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S.
Read more : https://www.statnews.com/2018/12/12/kaleo-evzio-overdose-antidote-generic/
Sun Pharmaceutical Industries, India's largest drug maker said its net profit jumped 286.1 percent to Rs 1,241.1 crore in the third quarter ended December 2018, beating analyst estimates by a wide margin, helped by a strong recovery of US generics business.
Read more : https://www.moneycontrol.com/news/business/companies/sun-pharma-net-profit-rises-four-fold-to-rs-1241-1-crore-in-q3fy19-3522661.html
Israel-based generics giant Teva Pharmaceutical Industries today posted 2018 financial results, showing
Read more : https://www.thepharmaletter.com/article/teva-down-as-it-reports-lower-sales-and-profit-for-2018
Hyderabad-based vaccine company Bharat Biotech's co-founder Krishna Ella, the scientist-turned entrepreneur, harbours hopes of making a major dent in the Indian and global vaccine space.
Read more : https://www.businesstoday.in/sectors/pharma/bharat-biotech-eyes-largest-rabies-vaccine-maker-tag-after-gsk-deal/story/319599.html